Chávez-Castillo, MervinOrtega, ÁngelCudris-Torres, LorenaDuran, PabloRojas, MilagrosManzano, AlexanderGarrido, BermarySalazar, JuanSilva, AljadisRojas-Gomez, Diana MarcelaDe Sanctis, Juan B.Bermúdez, Valmore2021-10-052021-10-052021Chávez-Castillo, M.; Ortega, Á.; Cudris-Torres, L.; Duran, P.; Rojas, M.; Manzano, A.; Garrido, B.; Salazar, J.; Silva, A.; Rojas-Gomez, D.M.; et al. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?. Int. J. Mol. Sci. 2021, 22, 10370. https:// doi.org/10.3390/ijms22191037014220067https://hdl.handle.net/20.500.12442/8636Chronic pain (CP) is a severe clinical entity with devastating physical and emotional consequences for patients, which can occur in a myriad of diseases. Often, conventional treatment approaches appear to be insufficient for its management. Moreover, considering the adverse effects of traditional analgesic treatments, specialized pro-resolving lipid mediators (SPMs) have emerged as a promising alternative for CP. These include various bioactive molecules such as resolvins, maresins, and protectins, derived from ω-3 polyunsaturated fatty acids (PUFAs); and lipoxins, produced from ω-6 PUFAs. Indeed, SPMs have been demonstrated to play a central role in the regulation and resolution of the inflammation associated with CP. Furthermore, these molecules can modulate neuroinflammation and thus inhibit central and peripheral sensitizations, as well as long-term potentiation, via immunomodulation and regulation of nociceptor activity and neuronal pathways. In this context, preclinical and clinical studies have evidenced that the use of SPMs is beneficial in CP-related disorders, including rheumatic diseases, migraine, neuropathies, and others. This review integrates current preclinical and clinical knowledge on the role of SPMs as a potential therapeutic tool for the management of patients with CP.pdfengAttribution-NonCommercial-NoDerivatives 4.0 InternacionalChronic painSpecialized pro-resolving lipid mediatorsInflammationLong-term potentiationCentral nervous system sensitizationPolyunsaturated fatty acidsEicosanoidsNociceptionOmega 3 fatty acidsPain managementinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps:// doi.org/10.3390/ijms221910370https://www.mdpi.com/1422-0067/22/19/10370/htm